Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Paratek Pharmaceuticals Inc announced that Paratek has delivered the first procurement of NUZYRA to the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR)...
read more
Parcom Capital has acquired clinical research organization Viroclinics Biosciences.
read more
Parexel announced the acquisition of Vitrana, a provider of an AI-enabled, end-to-end pharmacovigilance (PV) technology platform that supports patient safety and drug safety operations.
read more
PAREXEL International Corporation and EMC Corporation have entered into an alliance to offer an end-to-end Regulatory Information Management (RIM) and Regulatory Content Management solution.
read more
Tuesday, November 27, 2012
PAREXEL International Corporation, a leading global biopharmaceutical services provider, and the National Taiwan University Hospital (NTUH) announced today that they have established an alliance. Under the agreement, PAREXEL and NTUH will collaborate...
read more
Thursday, November 08, 2018
SHYFT Analytics and PAREXEL announced the companies have entered into a strategic partnership that establishes SHYFT’s technology as an integral part of PAREXEL’s foundation for Real-World Evidence (RWE) generation and outcomes research for ...
read more
Monday, November 12, 2018
PAREXEL announced the appointment of new members to the Board of Directors following Pamplona Capital Management’s acquisition in September 2017.
read more
PAREXEL announced the appointment of Peyton Howell as Chief Commercial and Strategy Officer, effective May 7, 2018.
read more
Parexel has unveiled its COVID-19 Risk Mitigation offering, which leverages the company’s experience with global viral outbreaks.
read more
Monday, December 18, 2017
PAREXEL has introduced its enhanced Global Data Operations solution.
read more
Monday, September 26, 2016
PAREXEL International Corporation has announced that the company has entered into a definitive agreement to acquire ExecuPharm, Inc., a global functional service provider (FSP) serving the biopharmaceutical industry. The acquisition is expected to ...
read more
Thursday, October 03, 2019
Parexel announced the company has appointed John Bell Executive Vice President and Chief Quality Officer.
read more
Parexel announced Gavin Nichols has joined the company as Executive Vice President, Informatics and Information Technology.
read more
PAREXEL International Corporation, a global biopharmaceutical services provider, has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to...
read more
Wednesday, February 27, 2019
PAREXEL announced several new appointments that will enhance the company’s oncology expertise as oncology trials grow in number and complexity.
read more